Evercore ISI Group: Vertex Pharmaceuticals (VRTX.US) rating was raised and adjusted simultaneously from the market to superior to the market rating, with a target price of 438.00 US dollars.
Evercore ISI Group：上调Vertex Pharmaceuticals(VRTX.US)评级，由大市同步调整至优于大市评级, 目标价438.00美元。
Evercore ISI Group: Vertex Pharmaceuticals (VRTX.US) rating was raised and adjusted simultaneously from the market to superior to the market rating, with a target price of 438.00 US dollars.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.